Skip to main content
Clinical Trials/NCT04029519
NCT04029519CompletedPhase 3

A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation

Prollenium Medical Technologies Inc.6 sites in 1 country84 target enrollmentStarted: December 21, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
84
Locations
6
Primary Endpoint
Change From Baseline in Lip Fullness Grading Scale

Study Overview

Brief Summary

To evaluate the safety and efficacy of retreatment with PN40082 for lip augmentation.

Detailed Description

This is a multicenter, open-label clinical study of retreatment of subjects seeking lip augmentation who received treatment with either PN40082 or Restylane Silk in prior Protocol PRO 2018-02 (NCT04032977). Subjects meeting the inclusion/exclusion criteria will receive a single additional treatment with PN40082

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Masking Description

Open Label

Eligibility Criteria

Ages
21 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •In Protocol PRO 2018-02, the subject was in the per-protocol population, i.e., met all inclusion/

Exclusion Criteria

  • •; received study device, completed Visit 5 within the specified window; had LFGS score by the Blinded Evaluating Investigator at Visit 3/Month 2, and had no significant protocol violations that would affect the treatment evaluation.
  • •If female and of childbearing potential, a negative urine pregnancy test at Visit 1/Day 1 and the subject agrees to use adequate contraception during the study period
  • •Willing to give written informed consent
  • •Exclusion Criteria:
  • •Women who are pregnant, lactating, or planning a pregnancy

Arms & Interventions

PN40082

Experimental

All subjects in this study will receive one open-label treatment with PN40082.

Intervention: PN40082 (Device)

Outcomes

Primary Outcomes

Change From Baseline in Lip Fullness Grading Scale

Time Frame: Visit 1/Day 1 to Visit 3/Month 2, 56 Days

Lip Fullness Grading Scale is a validated 5-point photonumeric rating scale with 0 being very thin lips (worse outcome) up to 4 full lips (best outcome)

Change From Baseline in Perioral Lines Severity Scale

Time Frame: Visit 1/Day 1 to Visit 3/Month 2, 56 Days

Change from baseline in the perioral lines rating scale (POL), a 4 point rating scale with 0 as a mouth with no perioral lines (better outcome) to 3 a mouth with many deep lines or crevices (worse outcome).

Secondary Outcomes

  • Number of Participants With Patient Global Aesthetic Improvement(Visit 1/Day 1 to Visit 3/Month 2, 56 days)
  • Number of Participants With Investigator Global Aesthetic Improvement(Visit 1/Day 1 to Visit 3/Month 2, 56 days)
  • Number of Subjects With Decreased Swelling(Visit 1/Day 1 to Visit 3/Month 2, 56 days)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (6)

Loading locations...

Similar Trials